FDA calendar: PDUFA dates and approval decisions
Upcoming PDUFA dates disclosed by companies, plus FDA approval decisions, complete response letters and advisory committee meetings. Every entry links to its drug and to the SEC filing or FDA record it came from. Subscribe to the calendar feed (.ics) or get upcoming dates by email each week.
1463 matching events. Showing the first 200; search or set a date range to see the rest. Partial dates are included when their reported period overlaps your range; undisclosed dates have their own view.
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 1953-07-27Day | Acetazolamide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA008943", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["DIAMOX"], "active_ingredients": ["ACETAZOLAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19530727", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1955-04-18Day | Hydroxychloroquine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA009768", "applicant_as_listed_by_fda": "ADVANZ PHARMA", "brand_names": ["PLAQUENIL"], "active_ingredients": ["HYDROXYCHLOROQUINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19550418", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1957-03-18Day | Chlorambucil | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA010669", "applicant_as_listed_by_fda": "WAYLIS THERAP", "brand_names": ["LEUKERAN"], "active_ingredients": ["CHLORAMBUCIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19570318", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1957-10-24Day | Methylprednisolone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA011153", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["MEDROL"], "active_ingredients": ["METHYLPREDNISOLONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19571024", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1958-10-30Day | Dexamethasone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA011664", "applicant_as_listed_by_fda": "MERCK", "brand_names": ["DECADRON"], "active_ingredients": ["DEXAMETHASONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19581030", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1959-11-16Day | Cyclophosphamide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA012141", "applicant_as_listed_by_fda": "BAXTER HLTHCARE", "brand_names": ["CYTOXAN"], "active_ingredients": ["CYCLOPHOSPHAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19591116", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1962-04-25Day | Fluorouracil | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA012209", "applicant_as_listed_by_fda": "SPECTRUM PHARMS", "brand_names": ["FLUOROURACIL"], "active_ingredients": ["FLUOROURACIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19620425", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1969-06-17Day | Cytarabine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA016793", "applicant_as_listed_by_fda": "TEVA PARENTERAL", "brand_names": ["CYTARABINE"], "active_ingredients": ["CYTARABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19690617", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1975-05-27Day | Dacarbazine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA017575", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["DTIC-DOME"], "active_ingredients": ["DACARBAZINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19750527", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1976-08-04Day | Lomustine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA017588", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["GLEOSTINE"], "active_ingredients": ["LOMUSTINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19760804", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1978-12-19Day | Cisplatin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA018057", "applicant_as_listed_by_fda": "HQ SPCLT PHARMA", "brand_names": ["CISPLATIN", "PLATINOL", "PLATINOL-AQ"], "active_ingredients": ["CISPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19781219", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1979-12-19Day | Daunorubicin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA050484", "applicant_as_listed_by_fda": "WYETH AYERST", "brand_names": ["CERUBIDINE"], "active_ingredients": ["DAUNORUBICIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19791219", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1980-04-10Day | Trifluridine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA018299", "applicant_as_listed_by_fda": "MONARCH PHARMS", "brand_names": ["VIROPTIC"], "active_ingredients": ["TRIFLURIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19800410", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1985-05-31Day | Dronabinol | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA018651", "applicant_as_listed_by_fda": "ALKEM LABS LTD", "brand_names": ["MARINOL"], "active_ingredients": ["DRONABINOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19850531", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1986-10-16Day | Somatropin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA019640", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["HUMATROPE"], "active_ingredients": ["SOMATROPIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19861016", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1989-03-03Day | Carboplatin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA019880", "applicant_as_listed_by_fda": "CORDEN PHARMA", "brand_names": ["PARAPLATIN"], "active_ingredients": ["CARBOPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19890303", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1989-12-29Day | goserelin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA019726", "applicant_as_listed_by_fda": "TERSERA", "brand_names": ["ZOLADEX"], "active_ingredients": ["GOSERELIN ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19891229", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1990-01-29Day | Fluconazole | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA019949", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["DIFLUCAN"], "active_ingredients": ["FLUCONAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19900129", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1990-09-27Day | Idarubicin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA050661", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IDAMYCIN"], "active_ingredients": ["IDARUBICIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19900927", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1991-04-18Day | Fludarabine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020038", "applicant_as_listed_by_fda": "GENZYME CORP", "brand_names": ["FLUDARA"], "active_ingredients": ["FLUDARABINE PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19910418", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1991-12-09Day | OnabotulinumtoxinA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103000", "applicant_as_listed_by_fda": "ALLERGAN", "brand_names": ["BOTOX", "BOTOX COSMETIC"], "active_ingredients": ["OnabotulinumtoxinA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19911209", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1992-12-29Day | Paclitaxel | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020262", "applicant_as_listed_by_fda": "HQ SPCLT PHARMA", "brand_names": ["TAXOL"], "active_ingredients": ["PACLITAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19921229", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1993-12-29Day | risperidone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020272", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["RISPERDAL"], "active_ingredients": ["RISPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19931229", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1994-04-08Day | Tacrolimus | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA050708", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["PROGRAF"], "active_ingredients": ["TACROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19940408", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1994-12-23Day | Vinorelbine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020388", "applicant_as_listed_by_fda": "PIERRE FABRE", "brand_names": ["NAVELBINE"], "active_ingredients": ["VINORELBINE TARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19941223", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1995-06-23Day | Valacyclovir | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020487", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE", "brand_names": ["VALTREX"], "active_ingredients": ["VALACYCLOVIR HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19950623", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1995-12-27Day | Anastrozole | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020541", "applicant_as_listed_by_fda": "ANI PHARMS", "brand_names": ["ARIMIDEX"], "active_ingredients": ["ANASTROZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19951227", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-05-14Day | Docetaxel | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020449", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["TAXOTERE"], "active_ingredients": ["DOCETAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960514", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-05-14Day | docetaxel | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020449", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["TAXOTERE"], "active_ingredients": ["DOCETAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960514", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-05-15Day | Gemcitabine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020509", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["GEMZAR"], "active_ingredients": ["GEMCITABINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960515", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-05-28Day | Topotecan | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020671", "applicant_as_listed_by_fda": "SANDOZ", "brand_names": ["HYCAMTIN"], "active_ingredients": ["TOPOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960528", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-06-14Day | Irinotecan | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020571", "applicant_as_listed_by_fda": "PFIZER INC", "brand_names": ["CAMPTOSAR"], "active_ingredients": ["IRINOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960614", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-09-30Day | Olanzapine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020592", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["ZYPREXA"], "active_ingredients": ["OLANZAPINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960930", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1996-09-30Day | olanzapine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020592", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["ZYPREXA"], "active_ingredients": ["OLANZAPINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960930", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-07-25Day | Letrozole | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020726", "applicant_as_listed_by_fda": "NOVARTIS PHARMS", "brand_names": ["FEMARA"], "active_ingredients": ["LETROZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970725", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-09-30Day | Irbesartan | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020757", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["AVAPRO"], "active_ingredients": ["IRBESARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970930", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-09-30Day | irbesartan | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020757", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["AVAPRO"], "active_ingredients": ["IRBESARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970930", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-11-26Day | Rituximab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103705", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["RITUXAN"], "active_ingredients": ["RITUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971126", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-11-26Day | rituximab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103705", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["RITUXAN"], "active_ingredients": ["RITUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971126", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1997-12-22Day | Repaglinide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020741", "applicant_as_listed_by_fda": "GEMINI LABS LLC", "brand_names": ["PRANDIN"], "active_ingredients": ["REPAGLINIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971222", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 19 Oct 2026 · Evidence last checked: 19 Oct 2026 |
| 1998-04-30Day | Capecitabine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020896", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["XELODA"], "active_ingredients": ["CAPECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19980430", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1998-09-25Day | Trastuzumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103792", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["HERCEPTIN"], "active_ingredients": ["TRASTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19980925", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1999-08-11Day | Temozolomide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021029", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["TEMODAR"], "active_ingredients": ["TEMOZOLOMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19990811", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 1999-10-21Day | Exemestane | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020753", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["AROMASIN"], "active_ingredients": ["EXEMESTANE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19991021", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2000-04-13Day | Meloxicam | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA020938", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["MOBIC"], "active_ingredients": ["MELOXICAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20000413", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2000-06-07Day | NovoLog | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA020986", "applicant_as_listed_by_fda": "NOVO NORDISK INC", "brand_names": ["NOVOLOG", "NOVOLOG FLEXPEN", "NOVOLOG FLEXTOUCH", "NOVOLOG INNOLET", "NOVOLOG PENFILL"], "active_ingredients": ["INSULIN ASPART RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20000607", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2001-03-16Day | Travoprost | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021257", "applicant_as_listed_by_fda": "ALCON PHARMS LTD", "brand_names": ["TRAVATAN"], "active_ingredients": ["TRAVOPROST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20010316", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2001-09-17Day | Darbepoetin alfa | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103951", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["ARANESP"], "active_ingredients": ["DARBEPOETIN ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20010917", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2001-10-26Day | tenofovir disoproxil | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021356", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["VIREAD"], "active_ingredients": ["TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20011026", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2001-10-26Day | Tenofovir | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021356", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["VIREAD"], "active_ingredients": ["TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20011026", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-01-31Day | Pegfilgrastim | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125031", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["NEULASTA"], "active_ingredients": ["PEGFILGRASTIM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020131", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-04-25Day | Fulvestrant | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021344", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["FASLODEX"], "active_ingredients": ["FULVESTRANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020425", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-05-24Day | Voriconazole | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021266", "applicant_as_listed_by_fda": "PF PRISM CV", "brand_names": ["VFEND"], "active_ingredients": ["VORICONAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020524", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-08-09Day | Oxaliplatin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021492", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["ELOXATIN"], "active_ingredients": ["OXALIPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020809", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-11-15Day | aripiprazole | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021436", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["ABILIFY"], "active_ingredients": ["ARIPIPRAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021115", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-11-26Day | Atomoxetine Hydrochloride | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021411", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["STRATTERA"], "active_ingredients": ["ATOMOXETINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021126", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2002-12-31Day | Adalimumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125057", "applicant_as_listed_by_fda": "ABBVIE INC", "brand_names": ["HUMIRA"], "active_ingredients": ["ADALIMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021231", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2003-05-13Day | Bortezomib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021602", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["VELCADE"], "active_ingredients": ["BORTEZOMIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20030513", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-02-04Day | Pemetrexed | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021462", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["ALIMTA"], "active_ingredients": ["PEMETREXED DISODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040204", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-02-12Day | cetuximab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125084", "applicant_as_listed_by_fda": "IMCLONE", "brand_names": ["ERBITUX"], "active_ingredients": ["CETUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040212", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-02-12Day | Cetuximab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125084", "applicant_as_listed_by_fda": "IMCLONE", "brand_names": ["ERBITUX"], "active_ingredients": ["CETUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040212", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-02-26Day | bevacizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125085", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["AVASTIN"], "active_ingredients": ["BEVACIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040226", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-02-26Day | Bevacizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125085", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["AVASTIN"], "active_ingredients": ["BEVACIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040226", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-05-19Day | Azacitidine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA050794", "applicant_as_listed_by_fda": "BRISTOL-MYERS", "brand_names": ["VIDAZA"], "active_ingredients": ["AZACITIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040519", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2004-11-18Day | Erlotinib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021743", "applicant_as_listed_by_fda": "OSI PHARMS", "brand_names": ["TARCEVA"], "active_ingredients": ["ERLOTINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20041118", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2005-03-29Day | entecavir | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021797", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["BARACLUDE"], "active_ingredients": ["ENTECAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20050329", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2005-03-29Day | Entecavir | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021797", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["BARACLUDE"], "active_ingredients": ["ENTECAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20050329", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2005-12-01Day | Sorafenib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021923", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["NEXAVAR"], "active_ingredients": ["SORAFENIB TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20051201", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2005-12-27Day | Lenalidomide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021880", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["REVLIMID"], "active_ingredients": ["LENALIDOMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20051227", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2006-01-26Day | Sunitinib Malate | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021938", "applicant_as_listed_by_fda": "CPPI CV", "brand_names": ["SUTENT"], "active_ingredients": ["SUNITINIB MALATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060126", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2006-05-02Day | Decitabine | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA021790", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["DACOGEN"], "active_ingredients": ["DECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060502", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2006-06-30Day | ranibizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125156", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["LUCENTIS"], "active_ingredients": ["RANIBIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060630", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2006-07-24Day | idursulfase | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125151", "applicant_as_listed_by_fda": "SHIRE", "brand_names": ["ELAPRASE"], "active_ingredients": ["IDURSULFASE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060724", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2006-09-27Day | panitumumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125147", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["VECTIBIX"], "active_ingredients": ["PANITUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060927", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2007-03-16Day | Eculizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125166", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["SOLIRIS"], "active_ingredients": ["ECULIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20070316", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2007-10-19Day | Sevelamer Carbonate | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022127", "applicant_as_listed_by_fda": "SANOFI", "brand_names": ["RENVELA"], "active_ingredients": ["SEVELAMER CARBONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20071019", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2007-11-14Day | Mircera® | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125164", "applicant_as_listed_by_fda": "HOFFMAN-LA ROCHE", "brand_names": ["MIRCERA"], "active_ingredients": ["METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20071114", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2008-02-27Day | Rilonacept | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125249", "applicant_as_listed_by_fda": "KINIKSA PHARMACEUTICALS (UK), LTD.", "brand_names": ["ARCALYST"], "active_ingredients": ["RILONACEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20080227", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2009-03-30Day | Everolimus | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022334", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["AFINITOR"], "active_ingredients": ["EVEROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090330", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2009-05-06Day | Iloperidone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022192", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["FANAPT"], "active_ingredients": ["ILOPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090506", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2009-05-06Day | iloperidone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022192", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["FANAPT"], "active_ingredients": ["ILOPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090506", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2009-09-24Day | Pralatrexate | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022468", "applicant_as_listed_by_fda": "ACROTECH BIOPHARMA", "brand_names": ["FOLOTYN"], "active_ingredients": ["PRALATREXATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090924", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2010-11-15Day | Eribulin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA201532", "applicant_as_listed_by_fda": "EISAI INC", "brand_names": ["HALAVEN"], "active_ingredients": ["ERIBULIN MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20101115", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-03-25Day | Ipilimumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125377", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["YERVOY"], "active_ingredients": ["IPILIMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110325", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-04-28Day | abiraterone | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-04-28Day | Abiraterone Acetate | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-08-26Day | Crizotinib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA202570", "applicant_as_listed_by_fda": "PF PRISM CV", "brand_names": ["XALKORI"], "active_ingredients": ["CRIZOTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110826", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-11-16Day | Ruxolitinib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA202192", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["JAKAFI"], "active_ingredients": ["RUXOLITINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20111116", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2011-11-18Day | Aflibercept | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125387", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["EYLEA"], "active_ingredients": ["AFLIBERCEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20111118", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2012-01-31Day | Ivacaftor | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA203188", "applicant_as_listed_by_fda": "VERTEX PHARMS", "brand_names": ["KALYDECO"], "active_ingredients": ["IVACAFTOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120131", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2012-06-08Day | Pertuzumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125409", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["PERJETA"], "active_ingredients": ["PERTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120608", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2012-08-31Day | Enzalutamide | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA203415", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["XTANDI"], "active_ingredients": ["ENZALUTAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120831", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2012-09-27Day | Regorafenib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA203085", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["STIVARGA"], "active_ingredients": ["REGORAFENIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120927", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2013-05-29Day | Trametinib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA204114", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["MEKINIST"], "active_ingredients": ["TRAMETINIB DIMETHYL SULFOXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20130529", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2013-11-01Day | Obinutuzumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125486", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["GAZYVA"], "active_ingredients": ["OBINUTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131101", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2013-11-01Day | obinutuzumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125486", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["GAZYVA"], "active_ingredients": ["OBINUTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131101", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 26 Oct 2026 · Evidence last checked: 26 Oct 2026 |
| 2013-11-13Day | Ibrutinib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205552", "applicant_as_listed_by_fda": "PHARMACYCLICS LLC", "brand_names": ["IMBRUVICA"], "active_ingredients": ["IBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131113", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-01-08Day | Dapagliflozin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA202293", "applicant_as_listed_by_fda": "ASTRAZENECA AB", "brand_names": ["FARXIGA"], "active_ingredients": ["DAPAGLIFLOZIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140108", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-01-31Day | Tasimelteon | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205677", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140131", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-01-31Day | tasimelteon | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205677", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140131", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-03-21Day | Apremilast | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205437", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["OTEZLA"], "active_ingredients": ["APREMILAST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140321", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-04-21Day | Ramucirumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125477", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["CYRAMZA"], "active_ingredients": ["RAMUCIRUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140421", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-05-20Day | Vedolizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125476", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["ENTYVIO"], "active_ingredients": ["VEDOLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140520", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-06-27Day | Afrezza | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA022472", "applicant_as_listed_by_fda": "MANNKIND", "brand_names": ["AFREZZA"], "active_ingredients": ["INSULIN RECOMBINANT HUMAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140627", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-07-03Day | Belinostat | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206256", "applicant_as_listed_by_fda": "ACROTECH BIOPHARMA", "brand_names": ["BELEODAQ"], "active_ingredients": ["BELINOSTAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140703", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-09-04Day | Pembrolizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125514", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA"], "active_ingredients": ["PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140904", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-09-04Day | pembrolizumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125514", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA"], "active_ingredients": ["PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140904", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-12-19Day | Olaparib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206162", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["LYNPARZA"], "active_ingredients": ["OLAPARIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141219", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-12-22Day | Nivolumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125554", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["OPDIVO"], "active_ingredients": ["NIVOLUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141222", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2014-12-22Day | nivolumab | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125554", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["OPDIVO"], "active_ingredients": ["NIVOLUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141222", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-07Day | RYTARY | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA203312", "applicant_as_listed_by_fda": "IMPAX", "brand_names": ["RYTARY"], "active_ingredients": ["CARBIDOPA", "LEVODOPA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150107", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-08Day | SAVAYSA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206316", "applicant_as_listed_by_fda": "DAIICHI SANKYO INC", "brand_names": ["SAVAYSA"], "active_ingredients": ["EDOXABAN TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150108", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-09Day | DUOPA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA203952", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["DUOPA"], "active_ingredients": ["CARBIDOPA", "LEVODOPA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150109", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-13Day | PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207026", "applicant_as_listed_by_fda": "VANTIVE US HLTHCARE", "brand_names": ["PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER", "PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER"], "active_ingredients": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM BICARBONATE", "SODIUM CHLORIDE", "SODIUM PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150113", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-13Day | PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207026", "applicant_as_listed_by_fda": "VANTIVE US HLTHCARE", "brand_names": ["PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER", "PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER"], "active_ingredients": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM BICARBONATE", "SODIUM CHLORIDE", "SODIUM PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150113", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-21Day | PRESTALIA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205003", "applicant_as_listed_by_fda": "ADHERA", "brand_names": ["PRESTALIA"], "active_ingredients": ["AMLODIPINE BESYLATE", "PERINDOPRIL ARGININE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150121", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-21Day | COSENTYX | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125504", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["COSENTYX"], "active_ingredients": ["SECUKINUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150121", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-23Day | TRIFERIC | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206317", "applicant_as_listed_by_fda": "ROCKWELL MEDICAL INC", "brand_names": ["TRIFERIC"], "active_ingredients": ["FERRIC PYROPHOSPHATE CITRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150123", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-23Day | NATPARA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125511", "applicant_as_listed_by_fda": "NPS PHARMS INC", "brand_names": ["NATPARA"], "active_ingredients": ["PARATHYROID HORMONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150123", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-29Day | EVOTAZ | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206353", "applicant_as_listed_by_fda": "BRISTOL", "brand_names": ["EVOTAZ"], "active_ingredients": ["ATAZANAVIR SULFATE", "COBICISTAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150129", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-01-30Day | GLYXAMBI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206073", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["GLYXAMBI"], "active_ingredients": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150130", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-03Day | Palbociclib | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207103", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IBRANCE"], "active_ingredients": ["PALBOCICLIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150203", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-03Day | IBRANCE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207103", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IBRANCE"], "active_ingredients": ["PALBOCICLIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150203", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-06Day | DUTREBIS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206510", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["DUTREBIS"], "active_ingredients": ["LAMIVUDINE", "RALTEGRAVIR POTASSIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150206", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-13Day | LENVIMA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206947", "applicant_as_listed_by_fda": "EISAI INC", "brand_names": ["LENVIMA"], "active_ingredients": ["LENVATINIB MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150213", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-23Day | FARYDAK | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205353", "applicant_as_listed_by_fda": "SECURA", "brand_names": ["FARYDAK"], "active_ingredients": ["PANOBINOSTAT LACTATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150223", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-25Day | AVYCAZ | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206494", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["AVYCAZ"], "active_ingredients": ["AVIBACTAM SODIUM", "CEFTAZIDIME"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-25Day | TOUJEO SOLOSTAR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA206538", "applicant_as_listed_by_fda": "SANOFI US SERVICES", "brand_names": ["TOUJEO MAX SOLOSTAR", "TOUJEO SOLOSTAR"], "active_ingredients": ["INSULIN GLARGINE RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-25Day | TOUJEO MAX SOLOSTAR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA206538", "applicant_as_listed_by_fda": "SANOFI US SERVICES", "brand_names": ["TOUJEO MAX SOLOSTAR", "TOUJEO SOLOSTAR"], "active_ingredients": ["INSULIN GLARGINE RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-02-26Day | LILETTA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206229", "applicant_as_listed_by_fda": "MEDICINES360", "brand_names": ["LILETTA"], "active_ingredients": ["LEVONORGESTREL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150226", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-06Day | CRESEMBA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207500", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["CRESEMBA"], "active_ingredients": ["ISAVUCONAZONIUM SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150306", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-06Day | ZARXIO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125553", "applicant_as_listed_by_fda": "SANDOZ INC", "brand_names": ["ZARXIO"], "active_ingredients": ["FILGRASTIM-SNDZ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150306", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-10Day | UNITUXIN | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125516", "applicant_as_listed_by_fda": "UNITED THERAP", "brand_names": ["UNITUXIN"], "active_ingredients": ["DINUTUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150310", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-17Day | Cholic acid | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-17Day | Cholic Acid | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-17Day | CHOLBAM | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-26Day | ORALTAG | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205383", "applicant_as_listed_by_fda": "INTERPHARMA PRAHA AS", "brand_names": ["ORALTAG"], "active_ingredients": ["IOHEXOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150326", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-30Day | JADENU | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206910", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["JADENU"], "active_ingredients": ["DEFERASIROX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150330", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-31Day | PROAIR RESPICLICK | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205636", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["PROAIR DIGIHALER", "PROAIR RESPICLICK"], "active_ingredients": ["ALBUTEROL SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150331", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-03-31Day | PROAIR DIGIHALER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205636", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["PROAIR DIGIHALER", "PROAIR RESPICLICK"], "active_ingredients": ["ALBUTEROL SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150331", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-04-17Day | APTENSIO XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205831", "applicant_as_listed_by_fda": "RHODES PHARMS", "brand_names": ["APTENSIO XR"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150417", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-04-29Day | KYBELLA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206333", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["KYBELLA"], "active_ingredients": ["DEOXYCHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150429", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-04-30Day | TUZISTRA XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207768", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["TUZISTRA XR"], "active_ingredients": ["CHLORPHENIRAMINE POLISTIREX", "CODEINE POLISTIREX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150430", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-14Day | FLOWTUSS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022424", "applicant_as_listed_by_fda": "CHARTWELL RX", "brand_names": ["FLOWTUSS"], "active_ingredients": ["GUAIFENESIN", "HYDROCODONE BITARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150514", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-14Day | HYCOFENIX | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022279", "applicant_as_listed_by_fda": "CHARTWELL RX", "brand_names": ["HYCOFENIX"], "active_ingredients": ["GUAIFENESIN", "HYDROCODONE BITARTRATE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150514", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-18Day | INVEGA HAFYERA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207946", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["INVEGA HAFYERA", "INVEGA TRINZA"], "active_ingredients": ["PALIPERIDONE PALMITATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150518", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-18Day | INVEGA TRINZA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207946", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["INVEGA HAFYERA", "INVEGA TRINZA"], "active_ingredients": ["PALIPERIDONE PALMITATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150518", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-21Day | STIOLTO RESPIMAT | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206756", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["STIOLTO RESPIMAT"], "active_ingredients": ["OLODATEROL HYDROCHLORIDE", "TIOTROPIUM BROMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150521", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-05-27Day | VIBERZI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206940", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VIBERZI"], "active_ingredients": ["ELUXADOLINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150527", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-06-22Day | TUXARIN ER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206323", "applicant_as_listed_by_fda": "MAINPOINTE", "brand_names": ["TUXARIN ER"], "active_ingredients": ["CHLORPHENIRAMINE MALEATE", "CODEINE PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150622", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-06-22Day | KENGREAL | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA204958", "applicant_as_listed_by_fda": "CHIESI", "brand_names": ["KENGREAL"], "active_ingredients": ["CANGRELOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150622", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-02Day | ORKAMBI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206038", "applicant_as_listed_by_fda": "VERTEX PHARMS INC", "brand_names": ["ORKAMBI"], "active_ingredients": ["IVACAFTOR", "LUMACAFTOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150702", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-07Day | ENTRESTO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207620", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["ENTRESTO"], "active_ingredients": ["SACUBITRIL", "VALSARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150707", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-10Day | ENVARSUS XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206406", "applicant_as_listed_by_fda": "VELOXIS PHARMS INC", "brand_names": ["ENVARSUS XR"], "active_ingredients": ["TACROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150710", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-10Day | REXULTI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205422", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["REXULTI"], "active_ingredients": ["BREXPIPRAZOLE"], "submission_type": "ORIG", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20150710", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-15Day | EPIDUO FORTE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207917", "applicant_as_listed_by_fda": "GALDERMA LABS", "brand_names": ["EPIDUO FORTE"], "active_ingredients": ["ADAPALENE", "BENZOYL PEROXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150715", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-24Day | TECHNIVIE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207931", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["TECHNIVIE"], "active_ingredients": ["OMBITASVIR", "PARITAPREVIR", "RITONAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-24Day | DAKLINZA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206843", "applicant_as_listed_by_fda": "BRISTOL-MYERS SQUIBB", "brand_names": ["DAKLINZA"], "active_ingredients": ["DACLATASVIR DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-24Day | ODOMZO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205266", "applicant_as_listed_by_fda": "SUN PHARM", "brand_names": ["ODOMZO"], "active_ingredients": ["SONIDEGIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-24Day | PRALUENT | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125559", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["PRALUENT"], "active_ingredients": ["ALIROCUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-07-31Day | SPRITAM | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207958", "applicant_as_listed_by_fda": "APRECIA PHARMS", "brand_names": ["SPRITAM"], "active_ingredients": ["LEVETIRACETAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150731", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-08-18Day | ADDYI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022526", "applicant_as_listed_by_fda": "SPROUT PHARMS", "brand_names": ["ADDYI"], "active_ingredients": ["FLIBANSERIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150818", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-08-24Day | PROMACTA KIT | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207027", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["PROMACTA KIT"], "active_ingredients": ["ELTROMBOPAG OLAMINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150824", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-08-26Day | SYNJARDY | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206111", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["SYNJARDY"], "active_ingredients": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150826", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-08-27Day | REPATHA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125522", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["REPATHA"], "active_ingredients": ["EVOLOCUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150827", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-01Day | VARUBI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206500", "applicant_as_listed_by_fda": "TERSERA", "brand_names": ["VARUBI"], "active_ingredients": ["ROLAPITANT HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150901", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-04Day | XURIDEN | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208169", "applicant_as_listed_by_fda": "BTG INTL", "brand_names": ["XURIDEN"], "active_ingredients": ["URIDINE TRIACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150904", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-04Day | DURLAZA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA200671", "applicant_as_listed_by_fda": "HESP", "brand_names": ["DURLAZA"], "active_ingredients": ["ASPIRIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150904", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-17Day | VRAYLAR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA204370", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VRAYLAR"], "active_ingredients": ["CARIPRAZINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150917", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-18Day | TOLAK | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022259", "applicant_as_listed_by_fda": "HILL DERMACEUTICALS", "brand_names": ["TOLAK"], "active_ingredients": ["FLUOROURACIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150918", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-22Day | LONSURF | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207981", "applicant_as_listed_by_fda": "TAIHO ONCOLOGY", "brand_names": ["LONSURF"], "active_ingredients": ["TIPIRACIL HYDROCHLORIDE", "TRIFLURIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150922", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-25Day | TRESIBA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA203314", "applicant_as_listed_by_fda": "NOVO", "brand_names": ["TRESIBA"], "active_ingredients": ["INSULIN DEGLUDEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150925", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-09-25Day | RYZODEG 70/30 | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA203313", "applicant_as_listed_by_fda": "NOVO", "brand_names": ["RYZODEG 70/30"], "active_ingredients": ["INSULIN ASPART", "INSULIN DEGLUDEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150925", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-02Day | MORPHABOND ER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206544", "applicant_as_listed_by_fda": "OHEMO LIFE", "brand_names": ["MORPHABOND ER"], "active_ingredients": ["MORPHINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151002", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-05Day | ARISTADA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207533", "applicant_as_listed_by_fda": "ALKERMES INC", "brand_names": ["ARISTADA"], "active_ingredients": ["ARIPIPRAZOLE LAUROXIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151005", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-16Day | ENSTILAR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207589", "applicant_as_listed_by_fda": "LEO PHARMA AS", "brand_names": ["ENSTILAR"], "active_ingredients": ["BETAMETHASONE DIPROPIONATE", "CALCIPOTRIENE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151016", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-16Day | PRAXBIND | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA761025", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["PRAXBIND"], "active_ingredients": ["IDARUCIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151016", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-19Day | DYANAVEL XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208147", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["DYANAVEL XR"], "active_ingredients": ["AMPHETAMINE", "AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151019", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-21Day | VELTASSA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205739", "applicant_as_listed_by_fda": "VIFOR PHARMA", "brand_names": ["VELTASSA"], "active_ingredients": ["PATIROMER SORBITEX CALCIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151021", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-22Day | ONIVYDE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207793", "applicant_as_listed_by_fda": "IPSEN", "brand_names": ["ONIVYDE"], "active_ingredients": ["IRINOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151022", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-22Day | VIVLODEX | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207233", "applicant_as_listed_by_fda": "ICEUTICA OPERATIONS", "brand_names": ["VIVLODEX"], "active_ingredients": ["MELOXICAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151022", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-23Day | Trabectedin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207953", "applicant_as_listed_by_fda": "JANSSEN PRODS", "brand_names": ["YONDELIS"], "active_ingredients": ["TRABECTEDIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-23Day | YONDELIS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207953", "applicant_as_listed_by_fda": "JANSSEN PRODS", "brand_names": ["YONDELIS"], "active_ingredients": ["TRABECTEDIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-23Day | BELBUCA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207932", "applicant_as_listed_by_fda": "BDSI", "brand_names": ["BELBUCA"], "active_ingredients": ["BUPRENORPHINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-23Day | STRENSIQ | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125513", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["STRENSIQ"], "active_ingredients": ["ASFOTASE ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-29Day | UTIBRON NEOHALER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207930", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["UTIBRON NEOHALER"], "active_ingredients": ["GLYCOPYRROLATE", "INDACATEROL MALEATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151029", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-10-29Day | SEEBRI NEOHALER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207923", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["SEEBRI NEOHALER"], "active_ingredients": ["GLYCOPYRROLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151029", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-04Day | NUCALA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125526", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE LLC", "brand_names": ["NUCALA"], "active_ingredients": ["MEPOLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151104", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-05Day | GENVOYA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207561", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["GENVOYA"], "active_ingredients": ["COBICISTAT", "ELVITEGRAVIR", "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151105", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-10Day | COTELLIC | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA206192", "applicant_as_listed_by_fda": "GENENTECH INC", "brand_names": ["COTELLIC"], "active_ingredients": ["COBIMETINIB FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151110", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-13Day | TAGRISSO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208065", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["TAGRISSO"], "active_ingredients": ["OSIMERTINIB MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151113", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-16Day | DARZALEX | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA761036", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["DARZALEX"], "active_ingredients": ["DARATUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151116", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-20Day | NINLARO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208462", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["NINLARO"], "active_ingredients": ["IXAZOMIB CITRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151120", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-24Day | PORTRAZZA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125547", "applicant_as_listed_by_fda": "ELI LILLY CO", "brand_names": ["PORTRAZZA"], "active_ingredients": ["NECITUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151124", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-11-30Day | EMPLICITI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA761035", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["EMPLICITI"], "active_ingredients": ["ELOTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151130", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-12-04Day | QUILLICHEW ER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207960", "applicant_as_listed_by_fda": "NEXTWAVE PHARMS", "brand_names": ["QUILLICHEW ER"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151204", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-12-07Day | BENDEKA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208194", "applicant_as_listed_by_fda": "EAGLE PHARMS", "brand_names": ["BENDEKA"], "active_ingredients": ["BENDAMUSTINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151207", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-12-08Day | KANUMA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA125561", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["KANUMA"], "active_ingredients": ["SEBELIPASE ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151208", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-12-10Day | OTIPRIO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA207986", "applicant_as_listed_by_fda": "ALK ABELLO", "brand_names": ["OTIPRIO"], "active_ingredients": ["CIPROFLOXACIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151210", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
| 2015-12-11Day | ALECENSA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208434", "applicant_as_listed_by_fda": "HOFFMANN-LA ROCHE", "brand_names": ["ALECENSA"], "active_ingredients": ["ALECTINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151211", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |
Which sources have been checked?
We check SEC filings for company announcements and FDA sources for decisions and notices. Events without a clear match to a company or drug in our database stay unpublished. Scan dates show when checks last ran, not complete coverage.
- Company-disclosed PDUFA dates (SEC)
- Last completed scan: 14 Nov 2026, 17:11 UTC. Latest attempt failed; coverage may be delayed.
- CDER original approvals
- Last completed scan: 18 Nov 2026, 20:10 UTC.
- CDER approval history (Drugs@FDA)
- Last completed scan: 16 Nov 2026, 20:40 UTC.
- CBER original approvals
- Last completed scan: 03 Nov 2026, 21:10 UTC.
- FDA complete response letters
- Last completed scan: 17 Nov 2026, 22:10 UTC.
- FDA advisory committee notices
- Last completed scan: 06 Oct 2026, 23:10 UTC.
If a source gives only a month, quarter or year, we show that rather than an exact day. Learn about our sources
Background: what a PDUFA date is and what a complete response letter is.
Use these dates elsewhere: embed the calendar on your site or read it through the API.
PDUFA dates and the FDA calendar explained
What is a PDUFA date?
A PDUFA date is the target date by which the FDA aims to act on a new drug or biologics application under the Prescription Drug User Fee Act. Standard reviews target about ten months and priority reviews about six. Companies usually disclose the date in a press release or SEC filing once the FDA accepts the application. PDUFA target action date in the glossary
Is a PDUFA date the same as the FDA approval date?
No. The PDUFA date is when the FDA aims to finish its review. On or before that date the agency can approve the application, issue a complete response letter or extend the goal date. This calendar lists PDUFA dates and published FDA decisions as separate event types.
Where do the dates in this FDA calendar come from?
PDUFA dates come from company filings with the US Securities and Exchange Commission. Approval decisions, complete response letters and advisory committee meetings come from FDA publications and Federal Register notices. Every entry links to the source it was taken from.
What happens when a PDUFA date changes?
When a company discloses a revised goal date, the calendar shows the new date and the drug page keeps the earlier date with its source.
How do I add PDUFA dates to my own calendar?
Subscribe to the FDA calendar feed in Google Calendar, Apple Calendar or Outlook using the link on this page. The feed carries upcoming and recent published events reported with an exact day. FDA calendar feed (.ics)